Patents by Inventor James Fadool

James Fadool has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11746391
    Abstract: Disclosed are non-naturally occurring zebrafish, such as transgenic zebrafish, which comprise a mutation in the rhodopsin (rho) gene. Also disclosed are methods of identifying compounds useful in treating retinal-specific defects and disorders, such as degeneration. Further disclosed are methods of identifying mutations in the rhodopsin gene that can cause retinal-specific defects.
    Type: Grant
    Filed: October 7, 2020
    Date of Patent: September 5, 2023
    Assignee: The Florida State University Research Foundation, Inc.
    Inventor: James Fadool
  • Publication number: 20210032709
    Abstract: Disclosed are non-naturally occurring zebrafish, such as transgenic zebrafish, which comprise a mutation in the rhodopsin (rho) gene. Also disclosed are methods of identifying compounds useful in treating retinal-specific defects and disorders, such as degeneration. Further disclosed are methods of identifying mutations in the rhodopsin gene that can cause retinal-specific defects.
    Type: Application
    Filed: October 7, 2020
    Publication date: February 4, 2021
    Inventor: James Fadool
  • Patent number: 10907220
    Abstract: Disclosed are non-naturally occurring zebrafish, such as transgenic zebrafish, which comprise a mutation in the rhodopsin (rho) gene. Also disclosed are methods of identifying compounds useful in treating retinal-specific defects and disorders, such as degeneration. Further disclosed are methods of identifying mutations in the rhodopsin gene that can cause retinal-specific defects.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: February 2, 2021
    Assignee: The Florida State University Research Foundation Inc.
    Inventor: James Fadool
  • Publication number: 20180346998
    Abstract: Disclosed are non-naturally occurring zebrafish, such as transgenic zebrafish, which comprise a mutation in the rhodopsin (rho) gene. Also disclosed are methods of identifying compounds useful in treating retinal-specific defects and disorders, such as degeneration. Further disclosed are methods of identifying mutations in the rhodopsin gene that can cause retinal-specific defects.
    Type: Application
    Filed: May 7, 2018
    Publication date: December 6, 2018
    Inventor: James Fadool